Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). PhytoHealth's share price for the quarter that ended in Dec. 2025 was NT$13.5. PhytoHealth's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 198.6 Mil. Therefore, PhytoHealth's market cap for the quarter that ended in Dec. 2025 was NT$2,681.4 Mil.
PhytoHealth's quarterly market cap
increased
from Jun. 2025 (NT$2,750.9 Mil) to Sep. 2025 (NT$2,999.1 Mil) but then
declined
from Sep. 2025 (NT$2,999.1 Mil) to Dec. 2025 (NT$2,681.4 Mil).
PhytoHealth's annual market cap
declined
from Dec. 2023 (NT$4,310.0 Mil) to Dec. 2024 (NT$3,336.8 Mil) and
declined
from Dec. 2024 (NT$3,336.8 Mil) to Dec. 2025 (NT$2,681.4 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PhytoHealth's Enterprise Value for Today is NT$1,749.3 Mil.
PhytoHealth (TPE:4108) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
PhytoHealth Market Cap Related Terms
PhytoHealth Market Cap Historical Data
* Premium members only.
The historical data trend for PhytoHealth's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, PhytoHealth's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PhytoHealth Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PhytoHealth's Market Cap distribution charts can be found below:
* The bar in red indicates where PhytoHealth's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
PhytoHealth's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PhytoHealth (TPE:4108) has a Market Cap of NT$2,383.4 Mil as of Jul. 09, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PhytoHealth and its competitors. According to the industry distribution chart, PhytoHealth ranks #659 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 64.4%.
Is PhytoHealth's Market Cap too high?
PhytoHealth's current Market Cap is NT$2,383.4 Mil. Based on the distribution chart, PhytoHealth ranks #659 out of 1024 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, PhytoHealth has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PhytoHealth's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PhytoHealth ranks #659 out of 1024 companies for Market Cap. This places PhytoHealth in the lower half of its industry. The industry median Market Cap is 210.75. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 210.75, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PhytoHealth and its competitors. For the Drug Manufacturers industry, the median Market Cap is 210.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PhytoHealth's current Market Cap is NT$2,383.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PhytoHealth stock overvalued right now?
Based on GuruFocus' analysis, PhytoHealth (TPE:4108) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$15.95, compared to a current price of NT$12.00 — trading 24.8% below its estimated fair value. The current Market Cap is NT$2,383.4 Mil. PhytoHealth's overall GF Score™ is 72/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For PhytoHealth (TPE:4108), the current Market Cap is NT$2,383.4 Mil as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PhytoHealth (TPE:4108) Overvalued in 2026?
Based on GuruFocus' analysis, PhytoHealth stock appears to be undervalued.
The current stock price of NT$12.00 is trading 24.8% below its estimated GF Value™ of NT$15.95.
GuruFocus considers PhytoHealth to be Modestly Undervalued.
Key valuation signals for TPE:4108:
Market Cap: NT$2,383.4 Mil
GF Value™: NT$15.95 vs. price of NT$12.00 (24.8% below fair value)
No single metric tells the full story. See the TPE:4108 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PhytoHealth Corp engages in the research and development, production, manufacture, and sale of pharmaceutical drugs, cosmetics, Class B drugs, and dietary supplements. The company's product portfolio comprises White Blood Crystals Injection, White Pain Relief Soft Capsules, WhiteGilead, and White AminoSpeed supplements. Additionally, it is developing PHN031 (White Bone) for the prevention of osteoporosis; PHN033 (White Sugar) for the treatment of diabetic nephropathy; PHN016 for cancer treatment; and PHN017 for the treatment of cytokine storm. The company's reportable operating segments are: Pharmaceutical drugs and dietary supplement, which generate maximum revenue, Medical diagnostic products, and Precision medical equipment. Geographically, it derives maximum revenue from Taiwan.
72GF Score
Get the complete analysis for TPE:4108
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4108 has been successfully added to your 
